New DNA reader aims to solve mystery of childhood epilepsy cases

NCT ID NCT07396883

Not yet recruiting Knowledge-focused Sponsor: University Hospital, Strasbourg, France Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new DNA technology called long-read genome sequencing in 20 children with severe epilepsy whose standard genetic tests came back normal. The goal is to find hidden genetic causes that standard tests miss, which could lead to better treatments and genetic counseling. The study does not offer a cure or treatment, but aims to improve diagnosis and understanding of the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

childhood-onset epilepsy syndrome developmental and epileptic encephalopathy Drug Resistant Epilepsy epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY EPILEPSY IN CHILDREN

Contacts and locations

Locations

American Memorial Hospital

Reims, 51092, France
CHU Jean Minjoz

Besançon, 25000, France
CHU de Nancy - hôpital d'enfant

Vandœuvre-lès-Nancy, 54511, France
Hôpitaux Universitaires de Strasbourg

Strasbourg, 67098, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.